Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study. (Record no. 10959170)

MARC details
000 -LEADER
fixed length control field 01718 a2200469 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513221856.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200010s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0008-543X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/1097-0142(20001001)89:7<1547::aid-cncr19>3.0.co;2-p
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Papadimitriou, C A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20001017
245 00 - TITLE STATEMENT
Title Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: long-term results of a phase II study.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer
Date of publication, distribution, etc. Oct 2000
300 ## - PHYSICAL DESCRIPTION
Extent 1547-54 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Epirubicin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Granulocyte Colony-Stimulating Factor
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infusions, Intravenous
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Paclitaxel
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Moulopoulos, L A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vlahos, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Voulgaris, Z
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kiosses, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Georgoulias, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Gika, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Diakomanolis, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Michalas, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Dimopoulos, M A
773 0# - HOST ITEM ENTRY
Title Cancer
Related parts vol. 89
-- no. 7
-- p. 1547-54
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/1097-0142(20001001)89:7<1547::aid-cncr19>3.0.co;2-p">https://doi.org/10.1002/1097-0142(20001001)89:7<1547::aid-cncr19>3.0.co;2-p</a>
Public note Available from publisher's website

No items available.